FOXK2 and neoplasm: Furthermore, MP treatment promoted tumor progression, reversing the inhibitory effect of FOXK2 silencing on tumor proliferation, while MI treatment markedly weakened the malignant characteristics associated with FOXK2 overexpression (Figure 5B).